FDA, CDC Halt Use of Chikungunya Vaccine in Adults 60+ After Two Deaths Reported

On May 9, 2025, the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC) recommended a temporary pause in the use of Ixchiq, a live virus vaccine designed to prevent chikungunya virus infection, in adults aged 60 years and older. The recommendation follows reports of serious post-marketing adverse […]
Flu Shot Recipients “More Likely” to Get Influenza Than Unvaccinated

The American Medical Association (AMA) cites that the influenza vaccine is estimated to be 40-60 percent effective at preventing serious infections or death from the influenza virus that affects up to 40 million Americans every year. However, for the 2024-2025 flu “season” the influenza vaccine not only missed the mark on effectiveness, but is linked […]
HHS Halts Funding for Development of Next-Generation COVID Biologics

The U.S. Department of Health and Human Services (DHHS) has stopped U.S. government funding for the development of next-generation COVID-19 biologics by two companies, GeoVax, Inc. of Atlanta, Georgia and CastleVax, Inc. of New York. The project had been funded by Project NextGen, a Biden administration initiative under the U.S. Center for the Biomedical Advanced […]
CT Scan Radiation Linked to Cancer, Especially in Children

Computed Tomography (CT) scans use X-rays to provide detailed cross section images of the body’s internal organs, bones and soft tissues for the purpose of diagnosing disease and injuries. They’re commonly used to help detect and treat a wide range of conditions, from bone fractures and cancer tumors to heart disease and blood clots. CT […]
U.S. Army Soldiers Reinstated After Being Discharged for Refusing COVID Shots

The U.S. Department of Defense (DoD) has begun reinstating U.S. Army personnel involuntarily discharged in 2021 for refusing to comply with the Biden administration’s COVID-19 shot mandate for Americans serving in the Army, Navy, Marines, Air Force and other branches of the military. The COVID shot mandate, which was rescinded in 2023 under the National […]
Moderna Continues mRNA Norovirus “Vaccine” Trials Following Guillain-Barré Case

A first-ever norovirus “vaccine”—another experimental biological product produced by Moderna, Inc., using novel mRNA technology—may be on the horizon even though last month the U.S. Food and Drug Administration (FDA) paused Moderna’s late-stage clinical trial following a report of Guillain-Barré syndrome (GBS), a rare neurological side effect that has also surfaced in its RSV vaccine […]
